Medical Care Technologies Inc. Completes Tele-Health(TM) Suite Technology for Congestive Heart Failure
22 January 2010 - 11:30PM
Marketwired
Medical Care Technologies Inc. (OTCBB: MDCE) today announced the
completion of Tele-Health™ Suite 6.17 technology for Congestive
Heart Failure (CHF).
Using MDCE's remote monitoring Tele-Health™ Suite, CHF home
patients answer a range of pertinent health related questions. This
is supplemented with medical parameters including blood pressure
and weight. Data analysis is performed automatically by
Tele-Health™ Suite and then sent and reviewed by a healthcare
professional.
A study by the Department of Community and Family Medicine,
School of Public Health, Faculty of Medicine, and Chinese
University of Hong Kong found that coronary heart disease (CHD) is
the second leading cause of cardiovascular deaths in China. CHD
accounts for 22% of cardiovascular deaths in urban areas and 13% in
rural areas. Although mortality from CHD in China is relatively low
compared with Western levels, the burden of CHD has been
increasing. This is partly because of a worsening profile of risk
factors, such as an increased prevalence of hypertension,
hyperlipidaemia, overweight/obesity, diabetes, etc. and partly
because of an increase in the aged population.
According to the World Health Organization (WHO) estimates, in
2003, 16.7 million people around the globe die of CVD each year.
This is over 29% of all deaths globally. The report: "A Race
Against Time: The Challenge of Cardiovascular Disease in Developing
Economies," 2004 Columbia University, New York concluded that CVD
in China will increase by 57% by 2030 as compared to year 2000.
Ning Wu, President of MDCE, stated, "We are extremely pleased to
have completed this updated CHF application for our Tele-Health™
Suite. Research has demonstrated that on average, patients managing
their CHF via telehealth remote monitoring can reduce their health
care system utilization by up to 30%. This translates into
substantial savings for both the patient and the healthcare
system."
About Medical Care Technologies Inc.
Medical Care Technologies Inc. (www.medicaretech.com) is traded
under the symbol MDCE on the OTCBB and is based in London, England.
The Company is in the process of moving its portfolio of oil
resources into medical care technologies. The products/services
that the company hopes to acquire are intended to constitute a
healthcare delivery and wellness site, dedicated to helping Asian
consumers live healthier, more balanced lives. MDCE is planning to
provide advanced connectivity, internationally standardized and
secure business technology and information systems to assist the
Asian health industry -- physicians, pharmacists, medical
institutions, and consumers -- in accessing medical resources,
health services, education, wellness and pharmaceutical products
throughout Asia. MDCE is planning to distribute and provide
services at a diverse range of industry-leading product lines in
three segments: Medical Devices, Pharmaceuticals and
Nutraceuticals. Further information on the Company can be found at
www.sec.gov and the company's website at www.medicaretech.com.
Safe Harbor Statement
All statements contained in this press release, other than
statements of historical fact, are forward-looking statements,
including those regarding: MDCE's products, services, capabilities,
performance, opportunities, development and business outlook,
guidance on our future financial results and other projections or
measures of our future performance; the amount and timing of the
benefits expected from strategic initiatives and acquisitions or
from deployment of new or updated technologies, products, services
or applications; and other potential sources of additional revenue.
These statements are based on our current plans and expectations
and involve risks and uncertainties that could cause actual future
events or results to be different than those described in or
implied by such forward-looking statements. These risks and
uncertainties include those relating to: lack of operating history,
transitioning from a development company to an operating company,
difficulties in distinguishing MDCE's products and services,
ability to deploy MDCE's services and products, market acceptance
of our products and services; operational difficulties relating to
combining acquired companies and businesses; our ability to form
and maintain mutually beneficial relationships with customers and
strategic partners; changes in economic, political or regulatory
conditions or other trends affecting the healthcare, Internet,
information technology and healthcare and pharmaceutical
industries, and our ability to attract and retain qualified
personnel. Other risks and uncertainties may include, but are not
limited to: lack of or delay in market acceptance and fluctuations
in customer demand, dependence on a limited number of significant
customers, reliance on third party vendors and strategic partners,
ability to meet future capital requirements on acceptable terms,
continuing uncertainty in the global economy, and compliance with
federal and state regulatory requirement. Further information about
these matters can be found in our Securities and Exchange
Commission filings. We expressly disclaim any intent or obligation
to update these forward-looking statements. There can be no
assurance that the acquisition of GUC's assets will close. MDCE
must issue 57,300,000 shares of its common stock to GUC, or GUC's
designees in order to close the acquisition. Accounting for the
anticipated cancellation of 57,300,000 shares by Patricia
Traczykowski, MDCE will have 98,900,000 shares of its common stock
issued and outstanding upon the closing of the acquisition.
For Further Information: Ezra Smith C. Jones Consulting, Inc.
Tel: (727) 771-9500 Fax: (727) 771-9545 Email:
cjones@cjonesconsulting.com Web: www.cjonesconsulting.com
Medical Care Technologies (PK) (USOTC:MDCE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medical Care Technologies (PK) (USOTC:MDCE)
Historical Stock Chart
From Jul 2023 to Jul 2024